Evidence map›Paper›PMID 29196046›Full record

Trial reportThe Lancet. Respiratory medicine2018

Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial.

Nadia Alam, Erick Oskam, Patricia M Stassen, Pieternel van Exter, Peter M van de Ven, Harm R Haak, Frits Holleman, Arthur van Zanten, Hien van Leeuwen-Nguyen, Victor Bon and 5 more

2 registry-linked trialsAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in The Lancet. Respiratory medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 120 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01988428 nacompletednot on this map

A Prospective Randomized Controlled Trial to Investigate the Effects of Training Emergency Medical Services (EMS) Personnel in Recognizing and Initiating Treatment in the Prehospital Setting Together With Early Administration of Antibiotics for Patients Suspected of (Severe) Sepsis and Septic Shock

TypeinterventionalSponsorAmsterdam UMC, location VUmcRan2014 to 2017Enrolled2,672ConditionsSepsis, Severe Sepsis, Septic ShockArmsCeftriaxone 2000 mg
NCT04438187 nacompletednot on this mapstarted 2021, after this paper: background citation

Trial of Antimicrobial Restraint in Presumed Pneumonia

TypeinterventionalSponsorUniversity of Kansas Medical CenterRan2021 to 2022Enrolled186ConditionsHealthcare-Associated Pneumonia, SepsisArmsantimicrobial initiation
3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. [S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Guideline
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Nadia AlamSection of Acute Medicine, Department of Internal Medicine, VU University Medical Center, and The Institute for Cardiovascular Research (ICAR-VU), Vrije Universiteit, Amsterdam, the Netherlands.
Erick OskamDepartment of Emergency Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands.
Patricia M StassenSection of Acute Medicine, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, Netherlands.
Pieternel van ExterAmbulance Amsterdam, Amsterdam, Netherlands.
Peter M van de VenDepartment of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands.
Harm R HaakSection of Acute Medicine, Department of Internal Medicine, Máxima Medical Center, Eindhoven, Netherlands; Department of Internal Medicine, Division of General Internal Medicine, Maastricht University Medical Center and CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht, Netherlands.
Frits HollemanSection of Acute Medicine, Department of Internal Medicine, Academic University Medical Center, Amsterdam, Netherlands.
Arthur van ZantenDepartment of Intensive Care Medicine, Gelderse Vallei Hospital, Ede, Netherlands.
Hien van Leeuwen-NguyenSection of Acute Medicine, Department of Internal Medicine, Maasstad Hospital, Rotterdam, Netherlands.
Victor BonAmbulance Amsterdam, Amsterdam, Netherlands.
Bart A M DuineveldSection of Acute Medicine, Department of Internal Medicine, VU University Medical Center, and The Institute for Cardiovascular Research (ICAR-VU), Vrije Universiteit, Amsterdam, the Netherlands.
Rishi S Nannan PandaySection of Acute Medicine, Department of Internal Medicine, VU University Medical Center, and The Institute for Cardiovascular Research (ICAR-VU), Vrije Universiteit, Amsterdam, the Netherlands.
Mark H H KramerSection of Acute Medicine, Department of Internal Medicine, VU University Medical Center, and The Institute for Cardiovascular Research (ICAR-VU), Vrije Universiteit, Amsterdam, the Netherlands.
Prabath W B NanayakkaraSection of Acute Medicine, Department of Internal Medicine, VU University Medical Center, and The Institute for Cardiovascular Research (ICAR-VU), Vrije Universiteit, Amsterdam, the Netherlands. Electronic address: p.nanayakkara@vumc.nl.
PHANTASi Trial Investigators and the ORCA (Onderzoeks Consortium Acute Geneeskunde) Research Consortium the Netherlands

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmergency medical services (EMS) personnel have already made substantial contributions to improving care for patients with time-dependent illnesses, such as trauma and myocardial infarction. Patients with sepsis could also benefit from timely prehospital care.

methodsAfter training EMS personnel in recognising sepsis, we did a randomised controlled open-label trial in ten large regional ambulance services serving 34 secondary and tertiary care hospitals in the Netherlands. We compared the effects of early administration of antibiotics in the ambulance with usual care. Eligible patients were randomly assigned (1:1) using block-randomisation with blocks of size 4 to the intervention (open-label intravenous ceftriaxone 2000 mg in addition to usual care) or usual care (fluid resuscitation and supplementary oxygen). Randomisation was stratified per region. The primary outcome was all-cause mortality at 28 days and analysis was by intention to treat. To assess the effect of training, we determined the average time to antibiotics (TTA) in the emergency department and recognition of sepsis by EMS personnel before and after training. The trial is registered at ClinicalTrials.gov, number NCT01988428.

findings2698 patients were enrolled between June 30, 2014, and June 26, 2016. 2672 patients were included in the intention-to-treat analysis: 1535 in the intervention group and 1137 in the usual care group. The intervention group received antibiotics a median of 26 min (IQR 19-34) before arriving at the emergency department. In the usual care group, median TTA after arriving at the emergency department was 70 min (IQR 36-128), compared with 93 min (IQR 39-140) before EMS personnel training (p=0·142). At day 28, 120 (8%) patients had died in the intervention group and 93 (8%) had died in the usual care group (relative risk 0·95, 95% CI 0·74-1·24). 102 (7%) patients in the intervention group and 119 (10%) in the usual care group were re-admitted to hospital within 28 days (p=0·0004). Seven mild allergic reactions occurred, none of which could be attributed to ceftriaxone.

interpretationIn patients with varying severity of sepsis, EMS personnel training improved early recognition and care in the whole acute care chain. However, giving antibiotics in the ambulance did not lead to improved survival, regardless of illness severity.

fundingThe NutsOhra Foundation, Netherlands Society of Internal Medicine (NIV).

Indexed as

AgedAged, 80 and overAmbulancesAnti-Bacterial AgentsEmergency Medical ServicesFemaleHumansMaleNetherlandsSepsisTreatment OutcomeAnti-Bacterial Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.